Safety & Recalls
FDA Clears Infilbray, First Drug for Type 3 Gaucher Brain Symptoms
The FDA approved Infilbray (venglustat), the first drug to cross the blood-brain barrier and treat neurological symptoms of Type 3 Gaucher disease.
Tag
The FDA approved Infilbray (venglustat), the first drug to cross the blood-brain barrier and treat neurological symptoms of Type 3 Gaucher disease.